Cargando…
European position paper on polypharmacy and fall-risk-increasing drugs recommendations in the World Guidelines for Falls Prevention and Management: implications and implementation
Falls prevention and management in older adults is a critical global challenge. One of the key risk factors for falls is the use of certain medications. Therefore, to prevent medication-related falls, the following is recommended in the recent World Guidelines for Falls Prevention and Management: (1...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447263/ https://www.ncbi.nlm.nih.gov/pubmed/37452999 http://dx.doi.org/10.1007/s41999-023-00824-8 |
_version_ | 1785094523639037952 |
---|---|
author | van der Velde, Nathalie Seppala, Lotta J. Hartikainen, Sirpa Kamkar, Nellie Mallet, Louise Masud, Tahir Montero-Odasso, Manuel van Poelgeest, Eveline P. Thomsen, Katja Ryg, Jesper Petrovic, Mirko |
author_facet | van der Velde, Nathalie Seppala, Lotta J. Hartikainen, Sirpa Kamkar, Nellie Mallet, Louise Masud, Tahir Montero-Odasso, Manuel van Poelgeest, Eveline P. Thomsen, Katja Ryg, Jesper Petrovic, Mirko |
author_sort | van der Velde, Nathalie |
collection | PubMed |
description | Falls prevention and management in older adults is a critical global challenge. One of the key risk factors for falls is the use of certain medications. Therefore, to prevent medication-related falls, the following is recommended in the recent World Guidelines for Falls Prevention and Management: (1) assess for fall history and the risk of falls before prescribing potential fall-risk-increasing drugs (FRIDs), (2) use a validated, structured screening and assessment tool to identify FRIDs when performing a medication review, (3) include medication review and appropriate deprescribing of FRIDs as a part of the multifactorial falls prevention intervention, and (4) in long-term care residents, if multifactorial intervention cannot be conducted due to limited resources, the falls prevention strategy should still always include deprescribing of FRIDs. In the present statement paper, the working group on medication-related falls of the World Guidelines for Falls Prevention and Management, in collaboration with the European Geriatric Medicine Society (EuGMS) Task and Finish group on FRIDs, outlines its position on how to implement and execute these recommendations in clinical practice. Preferably, the medication review should be conducted as part of a comprehensive geriatric assessment to produce a personalized and patient-centered assessment. Furthermore, the major pitfall of the published intervention studies so far is the suboptimal implementation of medication review and deprescribing. For the future, it is important to focus on gaining which elements determine successful implementation and apply the concepts of implementation science to decrease the gap between research and practice. |
format | Online Article Text |
id | pubmed-10447263 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-104472632023-08-25 European position paper on polypharmacy and fall-risk-increasing drugs recommendations in the World Guidelines for Falls Prevention and Management: implications and implementation van der Velde, Nathalie Seppala, Lotta J. Hartikainen, Sirpa Kamkar, Nellie Mallet, Louise Masud, Tahir Montero-Odasso, Manuel van Poelgeest, Eveline P. Thomsen, Katja Ryg, Jesper Petrovic, Mirko Eur Geriatr Med Special Article Falls prevention and management in older adults is a critical global challenge. One of the key risk factors for falls is the use of certain medications. Therefore, to prevent medication-related falls, the following is recommended in the recent World Guidelines for Falls Prevention and Management: (1) assess for fall history and the risk of falls before prescribing potential fall-risk-increasing drugs (FRIDs), (2) use a validated, structured screening and assessment tool to identify FRIDs when performing a medication review, (3) include medication review and appropriate deprescribing of FRIDs as a part of the multifactorial falls prevention intervention, and (4) in long-term care residents, if multifactorial intervention cannot be conducted due to limited resources, the falls prevention strategy should still always include deprescribing of FRIDs. In the present statement paper, the working group on medication-related falls of the World Guidelines for Falls Prevention and Management, in collaboration with the European Geriatric Medicine Society (EuGMS) Task and Finish group on FRIDs, outlines its position on how to implement and execute these recommendations in clinical practice. Preferably, the medication review should be conducted as part of a comprehensive geriatric assessment to produce a personalized and patient-centered assessment. Furthermore, the major pitfall of the published intervention studies so far is the suboptimal implementation of medication review and deprescribing. For the future, it is important to focus on gaining which elements determine successful implementation and apply the concepts of implementation science to decrease the gap between research and practice. Springer International Publishing 2023-07-15 2023 /pmc/articles/PMC10447263/ /pubmed/37452999 http://dx.doi.org/10.1007/s41999-023-00824-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Special Article van der Velde, Nathalie Seppala, Lotta J. Hartikainen, Sirpa Kamkar, Nellie Mallet, Louise Masud, Tahir Montero-Odasso, Manuel van Poelgeest, Eveline P. Thomsen, Katja Ryg, Jesper Petrovic, Mirko European position paper on polypharmacy and fall-risk-increasing drugs recommendations in the World Guidelines for Falls Prevention and Management: implications and implementation |
title | European position paper on polypharmacy and fall-risk-increasing drugs recommendations in the World Guidelines for Falls Prevention and Management: implications and implementation |
title_full | European position paper on polypharmacy and fall-risk-increasing drugs recommendations in the World Guidelines for Falls Prevention and Management: implications and implementation |
title_fullStr | European position paper on polypharmacy and fall-risk-increasing drugs recommendations in the World Guidelines for Falls Prevention and Management: implications and implementation |
title_full_unstemmed | European position paper on polypharmacy and fall-risk-increasing drugs recommendations in the World Guidelines for Falls Prevention and Management: implications and implementation |
title_short | European position paper on polypharmacy and fall-risk-increasing drugs recommendations in the World Guidelines for Falls Prevention and Management: implications and implementation |
title_sort | european position paper on polypharmacy and fall-risk-increasing drugs recommendations in the world guidelines for falls prevention and management: implications and implementation |
topic | Special Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447263/ https://www.ncbi.nlm.nih.gov/pubmed/37452999 http://dx.doi.org/10.1007/s41999-023-00824-8 |
work_keys_str_mv | AT vanderveldenathalie europeanpositionpaperonpolypharmacyandfallriskincreasingdrugsrecommendationsintheworldguidelinesforfallspreventionandmanagementimplicationsandimplementation AT seppalalottaj europeanpositionpaperonpolypharmacyandfallriskincreasingdrugsrecommendationsintheworldguidelinesforfallspreventionandmanagementimplicationsandimplementation AT hartikainensirpa europeanpositionpaperonpolypharmacyandfallriskincreasingdrugsrecommendationsintheworldguidelinesforfallspreventionandmanagementimplicationsandimplementation AT kamkarnellie europeanpositionpaperonpolypharmacyandfallriskincreasingdrugsrecommendationsintheworldguidelinesforfallspreventionandmanagementimplicationsandimplementation AT malletlouise europeanpositionpaperonpolypharmacyandfallriskincreasingdrugsrecommendationsintheworldguidelinesforfallspreventionandmanagementimplicationsandimplementation AT masudtahir europeanpositionpaperonpolypharmacyandfallriskincreasingdrugsrecommendationsintheworldguidelinesforfallspreventionandmanagementimplicationsandimplementation AT monteroodassomanuel europeanpositionpaperonpolypharmacyandfallriskincreasingdrugsrecommendationsintheworldguidelinesforfallspreventionandmanagementimplicationsandimplementation AT vanpoelgeestevelinep europeanpositionpaperonpolypharmacyandfallriskincreasingdrugsrecommendationsintheworldguidelinesforfallspreventionandmanagementimplicationsandimplementation AT thomsenkatja europeanpositionpaperonpolypharmacyandfallriskincreasingdrugsrecommendationsintheworldguidelinesforfallspreventionandmanagementimplicationsandimplementation AT rygjesper europeanpositionpaperonpolypharmacyandfallriskincreasingdrugsrecommendationsintheworldguidelinesforfallspreventionandmanagementimplicationsandimplementation AT petrovicmirko europeanpositionpaperonpolypharmacyandfallriskincreasingdrugsrecommendationsintheworldguidelinesforfallspreventionandmanagementimplicationsandimplementation AT europeanpositionpaperonpolypharmacyandfallriskincreasingdrugsrecommendationsintheworldguidelinesforfallspreventionandmanagementimplicationsandimplementation |